Thor Advisors’s Edwards Lifesciences EW Stock Holding History

Thor Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$20K	Buy	+321	New	+$23.1K	1.05%	29

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Thor Advisors's EW Position: Q1 2020 in Review

Thor Advisors opened a new position in Edwards Lifesciences (EW) in Q1 2020: 321 shares worth $20K. The stake represents 1.05% of the portfolio and ranks #29 among its holdings.

1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

Thor Advisors held 321 shares of Edwards Lifesciences worth $20K as of Q1 2020.
Edwards Lifesciences was a new Thor Advisors position in Q1 2020.
Edwards Lifesciences made up 1.05% of Thor Advisors's portfolio in Q1 2020, its #29 holding.
1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Thor Advisors's 13F filing for Q1 2020, filed 18 May 2020.